FDA Approved: PAZOPANIB — Original Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approval of a generic pazopanib product from Teva Pharmaceuticals under an Original Application (ANDA 217517).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma
• Soft Tissue Sarcoma

Drugs mentioned

• Pazopanib (Pazopanib)

Snippet

ORIG AP for PAZOPANIB (PAZOPANIB)